Expect legislative baby steps, not big leaps on drug prices
Even though both parties agree on lowering drug prices, experts predict changes will be incremental.
Drug Pricing
4 takeaways from Tuesday’s Senate drug pricing hearing
Seven pharma executives were grilled on drug prices on Capitol Hill on Tuesday.
Live blog: Pharma execs on the Hill
The latest from the Senate Finance Committee’s grilling of pharma executives on Capitol Hill.
Clarity in DTC TV ad drug pricing
Belle Frank is chief strategy officer, global health practice at VMLY&R.
Johnson & Johnson to put list prices in TV drug ads
The drugmaker will add list prices to ads for Xarelto by the end of March.
Was President Trump’s plan to reduce drug prices DOA?
President Trump’s blueprint to lower drug prices hasn’t made it out of the brainstorm phase.
Cassidy, Warner draft bill to promote value-based payment models
Senators Bill Cassidy and Mark Warner are taking feedback from the public before introducing the bill.
The next five years of pharma: Pricing, biosimilars, and specialty medicines
A report from the IQVIA Institute for Human Data Science identified areas to watch through 2023.
‘The current system is flawed’: PhRMA’s Zirkelbach on pricing
Robert Zirkelbach, public affairs EVP at PhRMA, discussed the group’s legislative priorities at the Coalition for Healthcare Communication’s post-election conference on Tuesday.
Pfizer to resume price increases in January
The drugmaker will raise prices on 10% of its drug portfolio.
